If a supplied lot fails agreed specifications, we’ll replace it at no cost or refund its purchase price in full.
Quality test failed? Free replacement or full refund.
Off-spec? Free replacement or full refund.
FDA PCAC reviews 7 peptides for the 503A bulks list (BPC-157, KPV, TB-500, MOTs-C, Emideltide, Semax, Epitalon). Read our compounder's decision tree. Read our briefing →
FDA PCAC reviews 7 peptides for the 503A bulks list in July. Read →
FDA PCAC: 7 peptides under review. Read →
Khavinson bioregulator tetrapeptide (Ala-Glu-Asp-Leu, AEDL)
Overview
Bronchogen is a synthetic tetrapeptide bioregulator with the amino acid sequence Ala-Glu-Asp-Leu (AEDL, H-Ala-Glu-Asp-Leu-OH), developed by Professor Vladimir Khavinson's team at the St. Petersburg Institute of Bioregulation and Gerontology in Russia. It belongs to the Khavinson short-peptide (cytogen) family and is associated with bronchial-pulmonary tissue research. PubChem CID 11690869 lists the molecular formula C18H30N4O9 and a molecular weight of approximately 446.5 Da; vendor technical data sheets also list 446.44 Da. PubChem CID 471572 describes H-Glu-Asp-Leu-Ala-OH, a different residue order with the same molecular formula. It should not be treated as an equivalent sequence for Bronchogen. Research includes a 2011 DNA-binding mechanism study, a 2012 cell differentiation study, and a 2015 rat COPD model study. These publications originate from the Khavinson team and Russian/St. Petersburg research institutions. The evidence base is limited in scale; no double-blind human trials are reported in the cited English-language literature. Bronchogen is offered as a lyophilized linear tetrapeptide with a ≥99.0% HPLC specification. Ask sales for the matching batch COA; it records the analytical work actually completed. Any sequence evidence, water, residual-solvent, endotoxin, or raw-data requirement must be included in the agreed written scope before quotation.
Applications & buyer fit
Buyers for longevity-class peptides span research labs working on telomere, collagen, and circadian-rhythm models, plus cosmetic-formulation OEMs incorporating peptides like GHK-Cu into anti-aging finished products. Copper peptides in particular require attention to chelator-free water and EDTA-free buffers in downstream formulation work, incompatibility there is the most common cause of "the peptide didn't work" support tickets in this class.
Sourced for
Buyer fit
Documentation that ships
Procurement note: Copper peptides require chelator-free water and EDTA-free buffers in downstream formulation work.
Primary buyer fit: academic and contract research laboratories.
Specifications
Batch COAs and test reports
Each picture is a low-resolution preview of a report's first page, with batch and report numbers covered. For the full, clear report, ask our sales team, naming the product and strength.
Batch COABronchogen 20 mg
HPLC purity · MS identity
Batch COA
Full, clear copy from sales
Independent test fails? Full refund. How it works
Browse all COAs and reportsRegulatory note
Research-use-only reference material; not for human or veterinary use.
Selected literature
Frequently asked questions
Use the receiving laboratory's approved protocol for vehicle, preservation, handling, and route-specific labelling. Record the supplied lot and the information actually stated on its batch COA so the preparation remains traceable.
The three tetrapeptides share the Ala-Glu-Asp core. Review the COA matched to the offered or supplied lot first. If the buyer's written acceptance procedure requires full sequence-level differentiation, agree LC-MS/MS or another appropriate method, reporting format, timing, and buyer-funded cost before testing.
Send any vial from your order to an independent laboratory of your choice. If the report shows the product does not meet the specification on its COA — purity below the stated minimum, or an identity that does not match — share the report with our sales team and we refund that product in full.